Key Dates

Related Announcements

PAR-18-884 - Novel Approaches to Safe, Non-Invasive, Real Time Assessment of Human Placenta Development and Function Across Pregnancy (R01 - Clinical Trial Not Allowed)

PAR-18-885 - Novel Approaches to Safe, Non-Invasive, Real Time Assessment of Human Placenta Development and Function Across Pregnancy (R21 - Clinical Trial Not Allowed)

Issued by

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Purpose

The purpose of this Notice is to extend the expiration date for PAR-18-885, Novel Approaches to Safe, Non-Invasive, Real Time Assessment of Human Placenta Development and Function Across Pregnancy (R21 - Clinical Trial Not Allowed).

Therefore, with the addition/extension by one Application Due Date , PAR-18-885 will now expire on December 5, 2021.

The following sections in Part 1. Overview Information, Key Dates, have been changed:

Currently reads:

Application Due Date(s): December 4, 2018, December 4, 2019, December 4, 2020, by 5:00 PM local time of applicant organization.

Scientific Merit Review: March 2019, March 2020, March 2021

Advisory Council: May 2019, May 2020, May 2021

Earliest Start Date: July 2019, July 2020, July 2021

Expiration Date: December 5, 2020

Modified to read (in italics):

Application Due Date(s): December 4, 2018, December 4, 2019, December 4, 2020, December 6, 2021 by 5:00 PM local time of applicant organization.

Scientific Merit Review: March 2019, March 2020, March 2021, March 2022

Advisory Council: May 2019, May 2020, May 2021, May 2022

Earliest Start Date: July 2019, July 2020, July 2021, July 2022

Expiration Date: December 7, 2021

All other aspects of PAR-18-885 remain unchanged.

Inquiries

Please direct all inquiries to:

David H. Weinberg, PhD
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Telephone: 301-526-0349
Email: david.weinberg@nih.gov